Trials / Completed
CompletedNCT05394818
The Clinical Study of SHR-A2009 for Injection in Patients With Advanced Solid Tumors
An Open-label, Phase I Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Efficacy of SHR-A2009 for Injection in Patients With Advanced Solid Tumors
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 19 (actual)
- Sponsor
- Suzhou Suncadia Biopharmaceuticals Co., Ltd. · Industry
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
This study is an open-label, phase I clinical trial of SHR-A2009 in patients with advanced solid tumors. The whole study is divided into three stages: dose escalation, dose expansion and efficacy expansion.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | SHR-A2009 | The total dosage of SHR-A2009 was calculated according to the weight weighing results of the subjects before each administration, and was administered by intravenous drip. |
Timeline
- Start date
- 2022-07-21
- Primary completion
- 2024-04-30
- Completion
- 2024-04-30
- First posted
- 2022-05-27
- Last updated
- 2024-12-27
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT05394818. Inclusion in this directory is not an endorsement.